Andrew Mihalek headshot

Andrew D. Mihalek

Associate Professor
Unit: School of Medicine
Department: Department of Medicine, Pulmonary and Critical Care
Office location and address
University Hospital Pulmonary Clinic
81 Hospital Dr
Charlottesville, Virginia 22903
University of California-Davis School of Medicine, 2006, MD
Residency, Loyola University Medical Center, 2010
Fellowship, Harvard University, 2014

Dr. Mihalek spent a large portion of his formative years in northern California. He was raised in San Jose, received his undergraduate degree in molecular and cellular biology from the University of California, Berkeley, and obtained his medical degree from UC Davis School of Medicine. Between college and medical school, he worked evaluating pregnancy prevention programs at the Institute for Health Policy Studies at the University of California, San Francisco, where he met his wife, Samira.  

After residency and a chief resident year in internal medicine at Loyola University Medical Center, Dr. Mihalek completed his specialty training with a fellowship in pulmonary and critical care medicine at Harvard. Before joining UVA, Dr. Mihalek spent time at the National Institutes of Health researching the mechanisms of smoking-related lung injury.

Dr. Mihalek currently oversees the pulmonary medicine curriculum for the UVA School of Medicine. His clinical time is spent leading the development of an acute pulmonary embolus response team and serving as one of the co-directors for the multidisciplinary UVA Pulmonary Hypertension Clinic. 

Dr. Mihalek spends his time outside of work teaching his son how to throw a curve ball and trying to convince his daughter to not feed the family dog, Lucy, from the kitchen table.

Uptravi® (SelexiPag): tHe usErs dRug rEgistry
Source: Janssen Research & Development, LLC
July 01, 2021 – December 31, 2024
Uptravi® (SelexiPag): tHe usErs dRug rEgistry
Source: Actelion Pharmaceuticals US, Inc.
December 05, 2017 – December 31, 2024
A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION (ADVANCE-extension)
Source: United Therapeutics Corporation
February 22, 2019 – February 21, 2022
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Source: United Therapeutics Corporation
June 09, 2020 – December 17, 2021
MD-INMD-CV OPUS Registry Opsumit (Macitentan) Users Registry
Source: PRA Health Sciences
October 09, 2014 – October 08, 2021
Uptravi® (SelexiPag): tHe usErs dRug rEgistry
Source: Janssen Research & Development, LLC
July 14, 2020 – December 04, 2020
A StuDy eVAluatiNg the EffiCacy and Safety of RalinEpag To Improve Treatment OUTCOMES in PAH Patients
Source: Arena Pharmaceuticals, Inc.
December 18, 2018 – June 19, 2020